Expert consensus on the clinical application of immunotherapy in breast cancer: 2024
{{output}}
Background: Significant progress has been made in immunotherapy of breast cancer (BC) with the approval of multiple immune checkpoint inhibitors (ICIs), particularly in early and metastatic triple-negative breast cancer (TNBC) se... ...
